Luxonus Inc. is a company which uses the new principles of photoacoustic technology to develop image diagnostic devices which can provide super-high-resolution 3D imaging of blood vessels and lymph vessels safely and easily without using radiation exposure.
This novel technology is expected to improve image diagnostic accuracy, aid surgical strategy planning, and allow early decisions on pharmacological effects, thereby inspiring further innovation and allowing optimal treatments to be selected for people who previously would have had no therapeutic opportunities.
Photoacoustic imaging consists of detecting ultrasonic waves generated by laser irradiation (pulsed laser light) with an ultrasonic sensor, thereby allowing the formation of an image. It is a noninvasive technique that allows one to map the “whole picture” of organisms as an image.
By processing a huge volume of ultrasonic signals in parallel, this technique can construct three-dimensional images in real time and provides a visualization of how they change over time.
In addition, not only can the organism be analyzed as an image, but the existence of a specific component, as well as its variations, can be determined by color differences.
With this technique, it will be possible to image fine vascular networks and the physiological properties of blood such as oxygen saturation in a noninvasive manner and without X-ray exposure.
AIRBIC A22 Shinkawsaki 7-7
Please contact us from this email address